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Reaction mechanism of pyridoxal 5'-phosphate synthase:
detection of an enzyme-bound chromophoric intermediate
Abstract
Vitamin B6 is an essential metabolite in all organisms. De novo synthesis of the vitamin can occur
through either of two mutually exclusive pathways referred to as deoxyxylulose 5-phosphate-dependent
and deoxyxylulose 5-phosphate-independent. The latter pathway has only recently been discovered and
is distinguished by the presence of two genes, Pdx1 and Pdx2, encoding the synthase and glutaminase
subunit of PLP synthase, respectively. In the presence of ammonia, the synthase alone displays an
exceptional polymorphic synthetic ability in carrying out a complex set of reactions, including pentose
and triose isomerization, imine formation, ammonia addition, aldol-type condensation, cyclization, and
aromatization, that convert C3 and C5 precursors into the cofactor B6 vitamer, pyridoxal 5'-phosphate.
Here, employing the Bacillus subtilis proteins, we demonstrate key features along the catalytic path. We
show that ribose 5-phosphate is the preferred C5 substrate and provide unequivocal evidence that the
pent(ul)ose phosphate imine occurs at lysine 81 rather than lysine 149 as previously postulated. While
this study was under review, corroborative crystallographic evidence has been provided for imine
formation with the corresponding lysine group in the enzyme from Thermotoga maritima (Zein, F.,
Zhang, Y., Kang, Y.-N., Burns, K., Begley, T. P., and Ealick, S. E. (2006) Biochemistry 45,
14609-14620). We have detected an unanticipated covalent reaction intermediate that occurs subsequent
to imine formation and is dependent on the presence of Pdx2 and glutamine. This step most likely
primes the enzyme for acceptance of the triose sugar, ultimately leading to formation of the pyridine
ring. Two alternative structures are proposed for the chromophoric intermediate, both of which require
substantial modifications of the proposed mechanism.
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Vitamin B6 is an essential metabolite in all
organisms. De novo synthesis of the vitamin
can occur through either of two mutually
exclusive pathways referred to as
deoxyxylulose 5-phosphate (DXP)-dependent
and DXP-independent. The latter pathway
has only recently been discovered and is
distinguished by the presence of two genes,
Pdx1  and Pdx2, encoding the synthase and
glutaminase subunit of a glutamine
amidotransferase, respectively. In the
presence of ammonia, the synthase alone
displays an exceptional polymorphic synthetic
ability in carrying out a complex set of
reactions including pentose and triose
isomerization, imine formation, ammonia
addition, aldol-type condensation, cyclization
and aromatization, that convert C3 and C5
precursors into the cofactor B6 vitamer,
pyridoxal 5´-phosphate. Here, employing the
Bacillus subtilis proteins, we demonstrate key
features along the catalytic path. We show
that ribose 5-phosphate is the preferred C5
substrate and provide unequivocal evidence
that the pent(ul)ose phosphate imine occurs at
lysine 81, rather than lysine 149 as previously
postulated. While this paper was under
review corroborative crystallographic
evidence has been provided for imine
formation with the corresponding lysine
group in the enzyme from Thermotoga
mari t ima  (1). We have detected an
unanticipated covalent reaction intermediate
that occurs subsequent to imine formation
and is dependent on the presence of Pdx2 and
glutamine. This step most likely primes the
enzyme for acceptance of the triose sugar,
ultimately leading to formation of the
pyridine ring. Two alternative structures are
proposed for the chromophoric intermediate,
both of which require substantial
modifications of the proposed mechanism.
Pyridoxal 5´-phosphate (PLP) is an essential
cofactor of many enzymes in all-living systems.
It is involved in amino acid and carbohydrate
metabolism and has recently been implicated as
an antioxidant with a potent ability to quench
singlet oxygen and the superoxide anion (2-4).
Two distinct pathways for its de novo
biosynthesis have been identified (5-13). One,
referred to as the DXP-dependent pathway, is
found in a relatively small number of eubacteria
and has been extensively studied in Escherichia
coli. In this pathway, pyridoxine 5´-phosphate is
derived from DXP and 4-phosphohydroxy-L-
threonine (9,10). The second pathway, referred
to as DXP-independent, has only been identified
recently and appears to be far more prevalent,
i.e. in archaea, fungi, plants and the majority of
bacteria (2,13). It is characterized by the
presence of two genes, Pdx1  and Pdx2. The
corresponding proteins function together as a
glutamine amidotransferase, with Pdx2 as the
glutaminase domain and Pdx1 as the acceptor
domain. As a result of extensive labeling studies
in yeast and biochemical analysis with the
recombinant enzymes, the substrates of Pdx1
have recently been identified (11,12,14,15). In
the presence of Pdx1, Pdx2 and glutamine, a
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2combination of either ribose 5-phosphate (R5P)
or ribulose 5-phosphate (Ru5P) with either
glyceraldehyde 3-phosphate (G3P) or
dihydroxyacetone phosphate (DHAP), resulted
in the reconstitution of PLP biosynthesis. As
either of two pentose or triose sugar phosphates
could be utilized it was proposed that Pdx1 can
catalyze their isomerization (11).
In analogy to the reactions catalyzed by
imidazole glycerol-phosphate synthase
(HisH/HisF) (16) and thiazole synthase (17), it
has been hypothesized that a pentulose
phosphate imine adduct occurs during the
reaction sequence of Pdx1 and Pdx2, now
referred to as PLP synthase (11). The
observation of the expected mass for such an
adduct with the isolated recombinant protein
corroborated this hypothesis. This adduct was
proposed to involve lysine 149, as deduced from
tandem mass spectrometric analysis (11). With
the knowledge of substrates and product at hand
and furthermore, the observation that 2´-
hydroxypyridoxol is  converted into
pyridoxamine in whole yeast cells (18), a
mechanism of action was proposed (11). In this
context, Pdx1 appears to be exceptional in that it
can catalyze pentose and triose isomerizations,
imine formation, ammonia addition and aromatic
ring formation all in a single enzymatic system.
Many of the mechanistic steps proposed are
hypothetical and additional information on the
actual mechanism of such an intriguing enzyme
is highly desirable given its fundamental interest
and its potential as a drug target in certain
parasitic organisms (19,20).
Here we report on the identification of an
unanticipated Pdx1 reaction intermediate. This
intermediate is chromophoric; its formation is
subsequent to that of the imine adduct and is
concomitant with the release of phosphate from
the pent(ul)ose substrate. Furthermore, it is
dependent on glutamine hydrolysis by the Pdx2
subunit. In addition, we show that ribose 5-
phosphate is the preferred C5 substrate of Pdx1.
Lastly, while we can corroborate the
participation of a pent(ul)ose phosphate derived
imine as a reaction intermediate, this adduct is
now unequivocally shown to involve, in Bacillus
subtilis Pdx1, lysine 81 rather than lysine 149, as
previously suggested (11). In a publication
which appeared after the original submission of
this work, independent x-ray crystallographic
evidence has been presented for imine formation
at the equivalent lysine (lysine 82) in the enzyme
from Thermotoga maritima (1). Our results have
implications for the annotation of the active site
of Pdx1 and necessitate considerable revision of
the previously proposed mechanism (11).
EXPERIMENTAL PROCEDURES
Materials-The constructs pETBsPdx1,
pETBsPdx2 and pETBsPdx2-His6 described in
(12) and pETBsPdx1-His6 described in (21), in
addition to the mutants Pdx1-His6 D24A, Pdx1-
His6 K81A, Pdx1-His6 K149A, Pdx2-His6
H170N (21) were used in this study.
Site directed mutagenesis-Pdx1-His6 K81R
and Pdx1-His6 K149R were generated using the
QuikChange site-directed mutagenesis kit
(Stratagene) employing the following
oligonucleotides:  K81R forward 5’-
CCGGTAATGGCACGAGCGCGTATCGG-3’,
K 8 1 R  r e v e r s e  5 ’ -
CCGATACGCGCTCGTGCCATTACCGG-3’,
K 1 4 9 R  f o r w a r d  5 ’ -
CTATGCTTCGCACAAGAGGTGAGCCTGG-
3 ’  a n d  K 1 4 9 R  r e v e r s e  5 ’ -
CCAGGCTCACCTCTTGTGCGAAGCATAG-
3’ using pETBsPdx1-His6 as the template.
Expression and purification of all proteins were
carried out as described in (12).
Generation of free-Pdx1-Isolated Pdx1-His6
was incubated with 0.5 mM DL-G3P and 20 mM
ammonium sulfate for 3 hours at room
temperature, prior to dialysis against 20 mM
Tris-Cl pH 7.5, containing 20 mM sodium
chloride. Dialyzed protein samples were frozen
in liquid nitrogen and stored at –80°C until use.
Synthesis of [U-
14
C]- and [U-
13
C]-labeled
Ru5P and R5P-Uniform labeling of Ru5P with
either 
13
C- or 
14
C- was carried out by incubation
of the respective uniformly labeled glucose (0.5
mM) with enzymes of the pentose phosphate
pathway (hexokinase (2U), glucose 6-phosphate
dehydrogenase (1U), 6-phosphogluconic
dehydrogenase (1U)) in 50 mM Tris-Cl buffer,
pH 8 containing 10 mM MgCl2, and 0.6 mM of
each of ATP, NAD
+
 and NADP
+
 at 37°C for the
indicated time intervals. When labeled ribose-5-
phosphate was required, 1 unit of phospho-
riboisomerase was included.
PLP synthase activity assays-The activity of
PLP synthase was monitored in 96 well plates
(PowerWave™ Microplate Spectrophotometer,
Bio-Tek) by following the absorbance at 414
nm, due to the formation of PLP (12). Reactions
were carried out at 37°C in 50 mM Tris-Cl, pH
8, containing 20 µM of free-Pdx1 and 20 µM of
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3Pdx2, 1 mM DL-G3P and 20 mM glutamine
while varying the concentration of either R5P or
Ru5P in the range of 0.01-1.0 mM or 0.3–6 mM,
respectively.
HPLC/protein methods of Pdx1-Pdx1
species were separated by RP-HPLC (Agilent
1100 Series Capillary LC System) employing a
Zorbax SB C18 column (3.5 m, 0.5 x 150 mm).
Protein was eluted with a linear gradient of 0-
45% acetonitrile (v/v). Peak fractions were
collected and analyzed by either MALDI-TOF
(Bruker Ultraflex II) or ESI mass spectrometry
(Waters Q-TOF Ultima API). Pdx1 tryptic
peptides were separated by RP-HPLC
employing a Reprosil 100 C18 column (5 m,
100 x 4.6 mm) equilibrated in 0.05%
trifluoroacetic acid (TFA, v/v). Online addition
of scintillation liquid (Flo-scint A, Perkin Elmer)
and radio-detection (Radiomatic FLO-ONE-
Beta, Perkin Elmer) permitted identification of
radiolabeled fractions. A gradient of 0-60%
acetonitrile/0.5% TFA (v/v) at 1 ml/min was
established over 45 min, held for 5 min, raised to
80% acetonitrile/0.5% trifluoroacetic acid (v/v)
over 5 min, and then returned to the starting
conditions over 15 min. Fractions of interest
were analyzed by MALDI-TOF/TOF mass
spectrometry (Bruker Ultraflex II). Total protein
and phosphospecific staining was carried out
using SYPRO
®
 Ruby and Pro-Q
®
 Diamond
phosphoprotein gel stain according to the
manufacturer’s (Invitrogen) instructions and
(22), respectively.
Reconstitution of the chromophoric adduct-
Free-Pdx1 (20 M) was incubated with R5P in
the presence of either Pdx2 (20 M) and 10 mM
glutamine or 20 mM ammonium sulfate in 50
mM Tris-Cl buffer, pH 7.5.
Measurement of the release of inorganic
phosphate-The inorganic phosphate released was
monitored spectrophotometrically employing a
coupled enzyme assay (EnzChek
®
Phosphate
Assay Kit, Molecular Probes). Typically,
equimolar concentrations of Pdx1 and Pdx2 (20
M) were incubated with glutamine and the kit
constituents in 50 mM Tris-Cl pH 8.0 containing
20 mM MgC12. The reaction was started by
addition of R5P to a final volume of 300 l and
monitored by the increase in absorbance at 360
nm.
RESULTS
Detection of a chromophoric reaction
intermediate of PLP biosynthesis-During the
preliminary characterization of the PLP synthase
subunit, Pdx1, we frequently observed an
absorbance maximum at 315 nm with the freshly
isolated protein which gradually disappeared
over a period of days, in addition to the typical
maximum at 280 nm (Fig. 1). While this species
could not be assigned to any known
chromophore, denaturation experiments
indicated that it is covalently attached to the
protein (data not shown). Thus, to aid in its
characterization we attempted its reconstitution.
Addition of the individual sugar substrates to
Pdx1 alone did not affect the UV-visible
absorbance spectrum. However, if the
glutaminase subunit, Pdx2, and its substrate,
glutamine, were included in the presence of the
pent(ul)ose sugar, a time-dependent increase in
the absorbance at 315 nm was observed (Fig.
2A ). The increase was not observed in the
presence of either Pdx2 or glutamine alone
suggesting that formation of the chromophore is
dependent on glutamine hydrolysis. This was
corroborated by employing the catalytically
incompetent Pdx2 H170N mutant (21), which
does not allow formation of the chromophore
(Fig. 2A , inset). Pdx2 H170N can still bind
glutamine when complexed to Pdx1 (21), but is
unable to carry out its hydrolysis due to the
replacement of the catalytic histidine (23).
Interestingly, it was also possible to reconstitute
the chromophore employing ammonium sulfate
in place of Pdx2 and glutamine, albeit at a rate
approximately 10–fold slower (data not shown).
The rate of chromophore formation is a
function of the concentration of ribose 5-
phosphate (Fig. 2B) from which an apparent KM
(126 ± 27 µM) could be estimated. The
intriguing possibility that the species observed
may be a reaction intermediate of PLP formation
prompted us to test its catalytic competence.
Indeed, addition of a stoichiometric amount of
glyceraldehyde 3-phosphate resulted in
formation of the reaction product, PLP
(absorbance maximum at 414 nm) with a clear
isosbestic point at 348 nm (Fig. 2C ). The
involvement of the supposed active site residues,
D24 and K149 (11,24) in formation of the
chromophore could be confirmed by the inability
of the mutants, D24A and K149A to support its
formation (data not shown).
The site of covalent adduct formation is
lysine 81 of Pdx1-It was recently postulated that
one of the early steps in PLP biosynthesis is the
formation of an imine adduct between K149 of
 at H
auptbibliothek Universitaet Zuerich Irchel. Bereich Forschung, on Decem
ber 18, 2009
w
w
w
.jbc.org
D
ow
nloaded from
 
4Pdx1 and its pent(ul)ose substrate (11). As we
suspected that formation of the imine precedes
formation of the chromophore, we sought to
confirm its localization. In contrast to the
chromophoric adduct, the imine can be fully
reconstituted simply by preincubation of Pdx1
with the pent(ul)ose substrate (11). A tryptic
digest of the fully reconstituted imine adduct
was performed and the resulting peptide mixture
was analyzed by MALDI-TOF mass
spectrometry, but peak suppression prevented
identification of the modified peptide. It was
therefore, necessary to first partially reduce
sample complexity by isolating the peptide from
the complete protein digest. For this we
employed [U-
14
C]-labeled R5P to reconstitute
the imine, followed by tryptic digestion and RP-
HPLC as described above, permitting us to
identify the fraction containing the modified
peptide (Fig. 3A). Repetition of this experiment
using either natural abundance material or [U-
13
C]-labeled R5P followed by comparative
MALDI-TOF mass spectrometry of the
analogous fraction revealed peptides with
masses of 2686.246 Da and 2691.261 Da,
corresponding to the 
12
C and 
13
C-labeled species,
respectively (Fig. 3B). Unexpectedly, tandem
mass spectrometry of these peptides yielded MS-
MS spectra that matched the predicted
fragmentation pattern of the peptide,
MADPTIVEEVMNAVSIPVMAKAR (Fig. 3C),
corresponding to residues 61-83, with the
pentulose phosphate imine adduct residing at
K81 (
12
C predicted mass, 2686.286). An overlay
of the unlabeled and labeled spectra
substantiates incorporation of the label at K81
(data not shown). This implied that the imine
adduct in Pdx1 occurs at K81 rather than K149
as previously reported (11). Indeed, while this
paper was under review, the crystal structure of
Pdx1 from Thermotoga maritima with ribulose
5-phosphate bound was published, where imine
formation with the pentulose phosphate was
observed at K82 (equivalent to K81 in BsPdx1)
(1).
To corroborate the finding further, we
attempted reconstitution of the imine adduct
with the K81R/A and K149R/A mutants of
BsPdx1. ESI-MS analysis revealed that K149A
could not form the imine adduct (as has been
shown previously (11)) nor could K81A or
K81R. However, K149R retains the ability to
form the imine (Fig. 4). Furthermore, formation
of the chromophoric adduct could be observed
with K149R (albeit at a rate twelve times lower
than that of the wild-type, kcat = 0.020 min
-1
 and
0.240 min
-1
 for K149R and WT, respectively),
whereas no activity could be detected for K81R.
The difference in rate was mainly manifested in
the kcat, as the KM of K149R was close to that of
the wild-type (185 ± 26 µM and 126 ± 27 µM
for K149R and WT, respectively). However, we
were unable to detect formation of PLP with
K149R (data not shown).
R5P is the preferential C5 substrate of PLP
synthase-During the imine adduct reconstitution
experiments we noted a preference for R5P as a
substrate compared to Ru5P (Fig. 5A). This was
already reflected in previous analyses where
initial rates of PLP formation were substantially
higher with R5P as the C5 sugar (11,12).
However, in these analyses a fraction of the
isolated protein would have the C5 sugar
incorporated, thus interfering with an accurate
comparison of the efficiency of the C5 sugars in
PLP synthesis. In order to provide a more
precise assessment of PLP synthesis, we isolated
free-Pdx1 as described in the methods and
reassessed PLP formation. Under these
conditions, kcat values for R5P and Ru5P were
very similar (0.040 min
-1
 and 0.042 min
-1
),
whereas there was a 60-fold difference in the Km
values (0.053 mM and 3.18 mM, respectively)
(Fig. 5B).
The preferential binding of R5P was also
reflected in studies in which a mixture of [U-
14
C]-labeled Ru5P and R5P was synthesized
from [U-
14
C]-glucose as outlined in the methods.
After incubation of Pdx1 with this mixture, the
reaction was subjected to SDS-PAGE followed
by autoradiography to detect co-migration of the
label with Pdx1 (Fig. 5C). Indeed, a signal could
be detected (Fig. 5C). However, if phospho-
riboisomerase was omitted from the reaction
mixture, thus resulting in formation of [U-
14
C]-
Ru5P predominantly, no such signal could be
detected (Fig. 5C). Furthermore, we observed
that Pdx2 was not required for pentose binding
to Pdx1, indicating that the sugar can bind to
Pdx1 alone.
Characterization of the chromophoric
adduct-We employed RP-HPLC to assess the
feasibility of separating the imine and
chromophoric adduct, respectively, from the
unmodified Pdx1 protein, to further aid in their
characterization. In the first instance, we
selected a sample of isolated Pdx1 in which the
chromophore could no longer be observed. This
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5sample yielded two clearly resolvable peaks,
annotated a and b (Fig. 6A, sample 1). ESI-mass
spectrometry of these two peak fractions
revealed masses of 33049.0 Da and 32835.0 Da,
corresponding to the pent(ul)ose phosphate
imine (predicted mass difference 212 Da) and
free-protein,  respectively (Table 1).
Confirmation of the imine adduct was
substantiated by RP-HPLC analysis of the
reconstituted imine, for which an expected
increase in species a and a concomitant decrease
in species b was observed (Fig. 6A, sample 2).
Moreover, the presence of a phosphate group in
species a could be corroborated employing a
phosphospecific stain (Fig. 6B). The marker
protein, egg ovalbumin (45 kDa, contains two
phosphate groups) and alkaline phosphatase
treated Pdx1 acted as controls.
Upon treatment of reconstituted a  with
ammonium salt and subjection to RP-HPLC as
described for the imine adduct, three resolvable
peaks, a, b  and c were obtained. Notably, only
the newly observed species c had an absorbance
corresponding to that of the chromophore (Fig.
6 A , sample 3). ESI-mass spectrometry
confirmed that species a and b correspond to the
pent(ul)ose phosphate imine and free-protein,
respectively. Species c (observed mass 32,930
Da) on the other hand has an additional mass of
95 Da when compared to the native protein.
Tryptic digestion followed by separation of the
resulting peptides in a fashion analogous to that
described above for the imine adduct localized
the chromophoric adduct to K81 in Pdx1 (data
not shown). In addition, mass spectrometric
comparison of the relevant natural
 
abundance
and [U-
13
C]-labeled peptide revealed that the
adduct had retained all five-carbon atoms from
the pentose sugar. Furthermore, reconstitution of
the chromophore employing 
14
N- and 
15
N-
labeled ammonium sulfate in place of Pdx2 and
glutamine indicated that nitrogen was not
incorporated into the chromophore (data not
shown). Additionally, we observed that species c
did not stain positive for a phosphate group (Fig.
6B). In agreement with this, an enzyme assay
confirmed that inorganic phosphate was released
in an amount stoichiometric with the protein
concentration (Fig. 6C), and that its formation is
concomitant with the formation of the
chromophore (Fig. 6D ). The observed mass
spectrometric difference of 95 Da between
species b  (the free-protein) and species c
requires that in addition to the phosphate group
and one molecule of water, a proton is lost
during formation of the chromophore.
Furthermore, we observed by UV-visible
spectrophotometry that chromophore formation
(kcat 0.212 min
-1
) is approximately five times
faster than PLP formation (kcat 0.040 min
-1
),
indicating that it is not a rate-limiting step in the
reaction (Fig. 2C inset).
DISCUSSION
Vitamin B6 research has attracted renewed
attention recently for two reasons: firstly, for the
discovery of an alternate route of its de novo
biosynthesis, which is different from that
previously assumed to occur in most organisms
(2,3,11,12,19,20,25-27); secondly, the vitamin
appears to have previously unrecognized potent
antioxidant capabilities equivalent to those of
vitamins C and E and may thus play an
important role in the defense against oxidative
stress (2,4,28-31). Aside from the general
interest in the biosynthesis of the vitamin, the
potential of the pathway as a drug target has
provided a strong impetus to define the
mechanism of action of the proteins involved,
Pdx1 and Pdx2 (19,20). The participation of
only two proteins and the remarkable ability of
Pdx1 to carry out a variety of reaction steps
directly yielding PLP from primary metabolites,
are expected to warrant complex chemistry.
Here, the observation and characterization of an
unant icipated chromophoric  react ion
intermediate covalently bound to Pdx1 allows us
to formulate the early steps of catalysis, with the
consequence that the previously postulated
mechanism (11) must be revised. An alternative
mechanism is provided (Scheme 1).
As formation of neither the imine nor the
chromophore requires the presence of the triose
sugar, it is assumed that PLP synthesis is
initiated by binding of the pent(ul)ose sugar in
the Pdx1 active site. Despite the fact that the
enzyme can utilize both R5P (1) and Ru5P (2)
(Scheme 1) as substrates, there is a clear
preference for the pentose rather than the
pentulose sugar phosphate. Whereas R5P in
solution is normally present as an equilibrium of
three species i.e. the  and  furanoses and the
open-chain form, Ru5P exists only in the latter
form (32). The ring forms of R5P are the
predominant species in solution (64% for the 
and 36% for the -furanose compared to 0.1%
for the free aldehyde) (33). Thus, the preference
 at H
auptbibliothek Universitaet Zuerich Irchel. Bereich Forschung, on Decem
ber 18, 2009
w
w
w
.jbc.org
D
ow
nloaded from
 
6of PLP synthase for R5P may be manifested in
recognition of the ring form. Evidence has been
provided that R5P can be isomerized to Ru5P by
Pdx1 (11); as isomerization requires the open-
chain form of the sugar, we propose that PLP
synthase first binds the furanose form and
catalyzes its opening prior to isomerization to
Ru5P (2).
The next stage in PLP biosynthesis involves
formation of an imine adduct (3 ). It was
previously proposed that K149 is the active site
residue involved at this stage (11). Indeed, the
recently described structure of free-Pdx1 from
Geobacillus stearothermophilus, which folds as
a ()8 barrel (24), embraced a model of such an
imine adduct between Ru5P and Pdx1. This
model was based on the co-crystallization of the
cryoprotectant 2-methyl-2,4-pentanediol and a
sulfate ion, which were believed to mimic the
carbon backbone and phosphate, respectively, of
the pent(ul)ose phosphate substrate. However,
such a model necessitated a rather drastic
reorientation of K149, as it points away from the
active site. It is now clear from the present study
and the very recent one of (1) that the
pent(ul)ose phosphate imine occurs at the better
poised K81 rather than K149 in Pdx1.
Furthermore, our studies clearly indicate that the
pentose sugar remains covalently bound to K81
at least until formation of the chromophoric
adduct. This observation rules out the recently
proposed transfer of the pentulose phosphate
imine from K81 to K149 (1). However, we
cannot exclude the possibility that K149 is
involved in imine formation at a later step i.e.
subsequent to formation of the chromophore and
before the transimination with ammonia occurs.
Indeed, K149 is absolutely conserved in Pdx1
sequences and the site directed mutagenesis
studies clearly indicate that it has a role in PLP
formation. However, as the conservative K149R
mutant described here retains the ability to form
the chromophoric adduct, exemplified by a
lowered kcat but unaltered KM, we suggest that it
is likely that this residue could alternatively act
as an acid/base catalyst.
In this study, a key finding is provided by
the isolation and characterization of a novel
chromophoric reaction intermediate. The
accumula ted  exper imenta l  ev idence
demonstrates that the chromophoric group of
this intermediate is appended to the -amino
group of K81 and that the new residue has the
composition C5H6O2, corresponding to the
elimination of one equivalent of inorganic
phosphate, one molecule of water and one
additional proton from the original protonated
imine adduct (Scheme 1, 3). In combination with
the observed extinction coefficient (315=16,200
M
-1
cm
-1
) which clearly points to a -*
transition, these stringent requirements can be
accommodated by the two structural proposals
7a and 8b of Scheme 1. In both cases the path
involves dehydration of 3 to 4, initiated by the
removal of the acidic hydrogen at C3 of the
substrate, followed by a -elimination of the
phosphate group leading to 5 , in which the
iminium group is destabilized by the adjacent
keto group and suffers deprotonation to 6a that
can easily tautomerize to the desired
chromophoric adduct (7a ). This step is then
followed by addition of water to form 8a, the
tautomer of which, 9a, is an appropriate partner
for condensation with DHAP (10), the second
building block of vitamin B6, to give 11a. From
here on a sequence of mechanistically plausible
steps (11a-17a), involving dehydration (11a to
12a), tautomerization and a transimination step
with ammonia to cleave the covalent bond of the
substrate to the protein, can lead to the pyridine
ring moiety of 17a. Compound 17a has been
considered as a putative intermediate of PLP
biosynthesis (11) on the basis of the
demonstration by the Spenser group that its
dephosphorylated counterpart is transformed
into pyridoxamine by whole cells of
Saccharomyces cerevisiae (18); a hypothetical
mechanistic scheme for this transformation has
been outlined before (15,18).
The second possible structure, 8b, for the
chromophoric intermediate is accessible from 5
via addition of water to provide 6b followed by
acid catalyzed tautomerization of the latter to 7b,
which can collapse by the elimination of water
to the desired compound 8b. Nucleophilic attack
of its tautomeric form (9b) on DHAP to give
11b , followed by the usual combination of
tautomerizations, transimination and dehydration
steps provides an alternative pathway (11b to
18) for the eventual formation of PLP, which in
contrast to route A does not necessitate the
postulated intermediacy of 2´-hydroxypyridoxol
5´-phosphate (17a). It is interesting to note in
this context that preliminary experiments with
the B. subtilis protein failed to disclose any
 at H
auptbibliothek Universitaet Zuerich Irchel. Bereich Forschung, on Decem
ber 18, 2009
w
w
w
.jbc.org
D
ow
nloaded from
 
7observable activity upon incubation with this
compound.
The DXP-dependent pathway of vitamin B6
biosynthesis requires the interplay of seven
enzymes to form PLP, three of which are
exclusive to the pathway. Vitamin B6
biosynthesis has been extensively studied in E.
coli (5,7,10,34-36), and it has recently been
pointed out that much of the complexity arises
through the formation of 3-amino-1-
hydroxyacetone 1-phosphate (37); the action of a
total of four enzymes is required to facilitate its
biosynthesis. This complexity is substantially
reduced in the DXP-independent pathway,
where Pdx1 itself incorporates the nitrogen atom
and directly yields the cofactor vitamer PLP. In
this context, PLP synthase simply provides a
more economical solution to vitamin B6
biosynthesis compared to its E. coli counterpart.
In summary, significant progress has been
made towards the mechanistic understanding of
the PLP synthase reaction. But additional work
is necessary for the unequivocal identification of
the chromophoric intermediate described in this
work and for a more complete description of the
later steps of the mechanism. As PLP synthase is
one of the most conserved enzymes found in
nature, it is highly likely that the mechanism
proposed pertains to all organisms that utilize
the DXP-independent pathway for vitamin B6
synthesis.
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FIGURE LEGENDS
Fig. 1. UV-visible absorbance spectrum of freshly isolated Pdx1 (42 µM). In addition to the typical
protein maximum at 278 nm due to aromatic residues, an additional absorbance maximum at 315 nm
(indicated by the arrow) is observed.
Fig. 2. UV-visible absorbance changes of Pdx1 in the presence of R5P. (A) Reconstitution of the
chromophoric adduct. Incubation of Pdx1 (20 µM) in the presence of R5P (0.2 mM), Pdx2 (20 µM)
and glutamine (10 mM) results in an absorbance maximum at 315 nm. The spectra were recorded at 0,
1.5, 3, 4.5, 6, 7.5 and 9-minute intervals. The inset shows the increase in absorbance at 315 nm
observed when Pdx2 WT (solid line) was substituted for Pdx2 H170N (dotted line). (B) The rate of
chromophore formation is dependent on the concentration of R5P. The changes in absorbance at 315
nm were recorded as a function of the concentration of R5P (0-2 mM). Fitting of the data was
according to f(x) = a.x/b+x. (C) Demonstration of the catalytic competence of the chromophoric
adduct. The chromophoric adduct was first reconstituted as described in (A) and represents time = 0.
DL-G3P (0.4 mM) was then added and the spectra were recorded at 3, 9, 15, 25, 40 and 60-minute
intervals. A decrease in the absorbance at 315 nm concomitant with an increase in the absorbance at
414 nm due to the formation of PLP is evident. The inset demonstrates that chromophore formation
(black circles) precedes PLP formation (grey circles). The molar concentrations of adduct (315=
16,200 M
-1
cm
-1
) and PLP (415= 5380 M-1cm-1) are plotted as a function of time. Note, following
reconstitution of the adduct, dialysis was performed to remove excess R5P and glutamine and DL-
G3P (0.4 mM) was added (indicated by an arrow). The reaction was carried out in 50 mM Tris-Cl, pH
8.0.
Fig. 3. RP-HPLC and mass spectrometry of the Pdx1 imine adduct. (A) RP-HPLC elution profile of
tryptic peptides of Pdx1 preincubated with [U-
14
C]-labeled R5P. The black line indicates the
absorbance at 215 nm and the grey line indicates radioactivity detected. (B) MALDI-TOF mass
spectrometry of the fraction labeled (*) (retention time = 31 min). The spectra shown are an overlay
of the modified peptide identified by comparison of tryptic peptides of [U-
12
C]- and [U-
13
C]-labeled
R5P preincubated with Pdx1 as described in (A). The m/z are as indicated. (C) MALDI-TOF/TOF
analysis of the precursor ion m/z = 2686.272 [M
+
H]
+
, yielded a fragmentation pattern matching the
predicted profile for the peptide MADPTIVEEVMNAVSIPVMAK
†
AR (residues 61-83) with K81
forming the imine adduct (
†
). Observed b (grey) and y (black) ions are as indicated.
Fig. 4. Imine adduct formation by Pdx1 mutants. Shown are ESI-mass spectra of (A) Pdx1 WT, (B)
Pdx1 K149R, (C ) Pdx1 K81R in the presence (grey line) and absence (black line) of R5P
(preincubated for 3 hours at 37°C). The m/z of the different Pdx1 forms are as indicated.
Fig. 5. R5P is the preferential C5 substrate of Pdx1. (A) ESI-mass spectra of Pdx1 preincubated for 1
hour at 37°C with either R5P (sample 1) or Ru5P (sample 2). The mass of 32835 Da and 33047 Da
corresponds to that of the free-protein and imine adduct, respectively. (B) PLP biosynthesis as a
function of the concentration of R5P or Ru5P. The rate of PLP synthesis was determined from the
absorbance at 415 nm. Assays were carried out in 50 mM Tris-Cl pH 8.0 and at 37°C employing free-
Pdx1 (20 µM), Pdx2 (20 µM), glutamine (20 mM) and DL-G3P (1 mM), while varying the C5
substrate in the range of 0.0-0.4 mM (R5P) and 0-6 mM (Ru5P). Steady state kinetic parameters kcat
and KM were estimated by fitting to the Michaelis-Menten equation. (C) SDS-PAGE (15%) and
autoradiography of Pdx1, lane 1 preincubated with a mix of [U-
14
C]-labeled R5P and Ru5P, i.e.
phospho-riboisomerase was included in the synthesis (see methods); lane 2, as for lane 1 but in the
presence of Pdx2; lane 3, Pdx1 preincubated with [U-
14
C]-labeled Ru5P i.e. phospho-riboisomerase
was omitted from the synthesis (see methods); lane 4, as for lane 3 but in the presence of Pdx2.
Fig. 6. Characterization of the Pdx1 chromophoric adduct. (A) RP-HPLC of isolated Pdx1 (sample 1),
reconstituted imine adduct (sample 2), and reconstituted chromophoric adduct (sample 3). The
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11
absorbance was monitored at 280 nm and in the case of sample 3 also at 325 nm (area shown in
white). The species observed are labeled a, b  and c corresponding to the imine adduct, free-protein
and chromophoric adduct forms of Pdx1, respectively. (B) The upper panel shows SYPRO Ruby
staining of the loaded protein; lane 1, molecular mass standards, lanes 2-4, species a, b  and c,
respectively; lanes 5 and 6, Pdx1 (10 pmol) before and after treatment with alkaline phosphatase,
respectively. The lower panel shows phosphospecific staining of the same samples as in the upper
panel. (C) The release of inorganic phosphate was monitored employing a coupled enzyme assay;
molar concentrations measured are plotted as a function of time. Inorganic phosphate release is
concomitant with chromophore formation (D). In (C ) and (D), the solid, dashed and dotted lines
represent 10, 20 and 40 µM of protein respectively, demonstrating that both phosphate release and
chromophore formation are stoichiometric with the protein concentration.
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Table 1. Molecular mass of Pdx1 observed species
Sample Predicted mass (Da)
Observed mass
(Da)
Observed mass –
observed mass of b
*
a 33046.8 33047.0 212.1
b 32834.8 32834.9 -
c 32929.8 32930.2 95.3
*Difference in mass observed compared to that of the free-protein (sample b)
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Scheme 1.
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